-
Identifying risks for early onset pre-eclampsia.
Kraus M, Nicolaides K.
Womens Health (Lond) 2015;11:15-7. pdf -
First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing.
Kagan KO, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:42-7. pdf -
Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery.
Quezada MS, Francisco C, Dumitrascu-Biris D, Nicolaides KH, Poon LC.
Ultrasound Obstet Gynecol 2015;45:101-5. pdf -
Competing risks model in screening for preeclampsia by maternal characteristics and medical history.
Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH.
Am J Obstet Gynecol 2015;213:62.e1-62.e10. pdf -
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:249-66. pdf -
Maternal serum anti-Mallerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia.
Birdir C, Fryze J, Vasiliadis H, Nicolaides KH, Poon LC.
J Matern Fetal Neonatal Med 2015;28:865-8. pdf -
Clinical significance of first-trimester chorionic bumps: a matched case-control study.
Sana Y, Appiah A, Davison A, Nicolaides KH, Johns J, Ross JA.
Ultrasound Obstet Gynecol 2013;42:585-9. -
First-trimester metabolomic detection of late-onset preeclampsia.
Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K.
Am J Obstet Gynecol 2013;208:58. pdf -
Metabolomic analysis for first-trimester Down syndrome prediction.
Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K.
Am J Obstet Gynecol 2013;208:371. pdf -
Trichorionic and dichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management.
Chaveeva P, Kosinski P, Puglia D, Poon LC, Nicolaides KH.
Fetal Diagn Ther 2013;1:199-205. pdf -
Metabolomic analysis for first-trimester trisomy 18 detection.
Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides KH.
Am J Obstet Gynecol 2013;209:65. pdf -
Maternal thyroid function at gestational weeks 11-13 in twin pregnancies.
Ashoor G, Muto O, Poon LC, Muhaisen M, Nicolaides KH.
Thyroid 2013;23:1165-71. -
Maternal serum vitamin D levels at 11-13 weeks of gestation in preeclampsia.
Yu CK, Ertl R, Skyfta E, Akolekar R, Nicolaides KH.
Hum Hypertens 2013;27:115-8 . pdf -
Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes.
Poon LC, Musci T, Song K, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2013;33:215-23. pdf -
Maternal age and adverse pregnancy outcomes: a cohort study.
Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;42:634-43. pdf -
Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.
Gil MM, Quezada MS, Bregant B, Ferraro M, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;42:34-40. pdf -
How to record uterine artery Doppler in the first trimester.
Khalil A, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;42:478-9. pdf -
First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH, Wright D, Poon LC, Syngelaki A, Gil MM.
Ultrasound Obstet Gynecol 2013;42:41-50. pdf -
First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH, Syngelaki A, Poon LC, Gil M, Wright D.
Fetal Diagn Ther 2014;35:185-92. pdf -
Fetal heart defects: potential and pitfalls of first-trimester detection.
Khalil A, Nicolaides KH.
Neonatal Med 2013;18:251-60. pdf